This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is Invesco High Yield Equity Dividend Achievers ETF (PEY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PEY
Stock Market News for Jan 23, 2024
by Zacks Equity Research
Wall Street ended higher on Monday, driven by a surge in oil prices due to supply concerns, which propelled the Dow to a record-breaking 38,000.
Stock Market News for Jan 18, 2024
by Zacks Equity Research
Wall Street ended lower on Wednesday, as investors witnessed stronger-than-expected retail sales data and expect six interest rate cuts in 2024, as well as continue to keenly watch the fourth-quarter 2023 earnings results.
3 Large-Cap Stocks Seeing Insider Activity
by Derek Lewis
Insiders continue staying busy, recently scooping up shares of these three companies. What did they see?
Company News for Jan 5, 2024
by Zacks Equity Research
Companies In The News Are: WBA, LNN, MBLY, RPM.
Is Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RSPS
Walgreens (WBA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Walgreens (WBA) give a sense of how its business performed in the quarter ended November 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Walgreens Boots (WBA) Q1 Earnings Top Estimates, Margins Down
by Zacks Equity Research
Walgreens Boots' (WBA) comparable pharmacy sales in the fiscal first quarter benefited from higher branded drug inflation and strong execution in pharmacy services.
Weekly Jobless Claims Below Expectations
by Zacks Equity Research
Weekly Jobless Claims Below Expectations.
ADP, Jobless Claims Better than Expected
by Mark Vickery
ADP private-sector payrolls for December came in hotter than expected: 164K versus 130K consensus.
Walgreens Boots Alliance (WBA) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 4.76% and 5.10%, respectively, for the quarter ended November 2023. Do the numbers hold clues to what lies ahead for the stock?
Is Invesco Dow Jones Industrial Average Dividend ETF (DJD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DJD
Conagra, Lamb Weston, Walgreens Boots Alliance and Constellation Brands are part of Zacks Earnings Preview
by Zacks Equity Research
Conagra, Lamb Weston, Walgreens Boots Alliance and Constellation Brands are highlights of Zacks Earnings Preview article.
Should You Invest in the Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS)?
by Zacks Equity Research
Sector ETF report for RSPS
Exploring Analyst Estimates for Walgreens (WBA) Q1 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Get a deeper insight into the potential performance of Walgreens (WBA) for the quarter ended November 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
How Will Earnings Estimates Evolve in 2024?
by Sheraz Mian
The economy's resilience in the face of the Fed's extraordinary tightening has been a pleasant surprise. That said, it makes sense for growth to moderate going forward to reflect the cumulative effect of monetary policy tightening.
Walgreens (WBA) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Strength in U.S. Healthcare and International businesses is likely to drive Walgreens' (WBA) first-quarter 2024 performance.
Walgreens Boots Alliance (WBA) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $26.60, marking a -0.15% move from the previous day.
Earnings Preview: Walgreens Boots Alliance (WBA) Q1 Earnings Expected to Decline
by Zacks Equity Research
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Walgreens Boots Alliance (WBA) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) concluded the recent trading session at $26.22, signifying a +0.61% move from its prior day's close.
Can Dogs of the Dow ETFs Snap Losing Trend in 2024?
by Sanghamitra Saha
The Dogs of the Dow underperformed the broader market in 2023. However, with the Fed likely to cut rates in 2024, can these dividend dogs roar next year?
Should Invesco Dow Jones Industrial Average Dividend ETF (DJD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DJD
Conn's (CONN) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Conn's (CONN) delivered earnings and revenue surprises of -37.16% and 4.75%, respectively, for the quarter ended October 2023. Do the numbers hold clues to what lies ahead for the stock?
Walgreens Boots Alliance (WBA) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $24.98, moving -0.87% from the previous trading session.
Walgreens Boots Alliance (WBA) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
In the most recent trading session, Walgreens Boots Alliance (WBA) closed at $23, indicating a -0.69% shift from the previous trading day.